Journal articleProc Natl Acad Sci U S A2021
NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition.
- Journal
- Proc Natl Acad Sci U S A
- Published
- 1 February 2021
- Citations
- 30
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 6
- Core 1: Animal and Cell Model Core P01CA236585↗
- Multifunctional immunoPET tracers for pancreatic and prostate cancer R01CA174294↗
- PET Imaging-guided Personalized Therapy in Pancreatic Cancer R01CA187678↗
- Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer R01CA250529↗
- Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer R01CA260678↗
- UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer U01CA198846↗